Anzeige
Mehr »
Login
Mittwoch, 13.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Wir entschlüsseln die 55 $ pro Aktie Clean-Energy-Chance für SIE!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
618 Leser
Artikel bewerten:
(2)

Lucata Corporation: Lucata Continues Strong Momentum in 2021

Finanznachrichten News

NEW YORK, Jan. 20, 2022Corporation, provider of a next generation computing architectural extension to Intel technology for high performance, massively scalable graph analytics processing, today announced continued strong momentum for 2021. Major accomplishments included raising a Series B funding round, naming highly respected members to Lucata's Boards, launching the Lucata Pathfinder graph analytics processing server and demonstrating its tremendous performance advantages over conventional computing, and receiving recognition for Lucata's products based on the company's patented Migratory Thread technology.

"2021 was a remarkable year for Lucata as we increased our funding, continued building our organization, introduced our technology to the market, and successfully demonstrated its power to transform graph analytics," said Michael Maulick, Lucata CEO. "From deadly diseases and ever-rising threat of cyberattacks, to rampant financial fraud, our society is faced with challenges that only a major advance in computing hardware technology can address. Lucata Pathfinder enables organizations to use existing software to uncover much deeper connections within much larger graphs than possible today using conventional computing technology. This allows them to reimagine the potential of graph analytics. Beyond analytics, Lucata will also greatly reduce failures in AI and ML by eliminating the bias introduced from the pruning and sharding of data. 2022 promises to be a very exciting year as we deliver our technology at scale into the hands of customers."

Corporate Milestones

  • Raised $11.9 Million in Series B Funding to Introduce Next-Generation Computing Platform (https://lucata.com/about/news/lucata-series-b-funding-announcement/)
  • Awarded National Science Foundation Small Business Innovation Research Grant to Revolutionize Graph Database Technology (https://lucata.com/about/news/lucata-nsf-sbir-award-announcement/)
  • Named John Donovan to Board of Directors (https://lucata.com/about/news/lucata-names-john-donovan-to-board-of-directors-press-release/)
  • Named Michael D. Moore to Board of Advisors (https://lucata.com/about/news/lucata-names-michael-d-moore-to-board-of-advisors-press-release/)

Products Milestones

  • Announced Next Generation Computing Platform That Shatters the Performance Limits of Conventional Computers for Graph Analytics (https://lucata.com/about/news/lucata-pathfinder-performance-announcement/)
  • Demonstrated Breakthrough Graph Analytics Processing Efficiency by Ranking #46 on the Green Graph500 Benchmark (https://lucata.com/about/news/lucata-pathfinder-demonstrates-breakthrough-graph-analytics-processing-efficiency-by-ranking-46-on-green-graph500-benchmark/)
  • Delivered First Commercially Available System to Enable Banks to Detect Fraud in Real-Time (https://lucata.com/about/news/lucata-delivers-first-commercially-available-system-to-enable-banks-to-detect-fraud-in-real-time-press-release/)

Awards

  • Named Best Thread Technology Computing Platform (https://www.thenewworldreport.com/issues/software-and-tech-2021/16/) in New World Report 2021 Software and Technology Awards

Lucata Pathfinderenables organizations to leverage massive pools of physical memory to accelerate and scale graph analytics and AI and ML model training by orders of magnitude beyond the capabilities of conventional computing approaches. The solution enables high-performance exascale graph analytics, including exhaustive breadth-first search (BFS), on unpruned, unsharded massive graph databases. Lucata can be used with open source, commercial graph software or with custom-written graph solutions that leverage LAGraph, GraphBLAS, or the Lucata library of algorithms, enabling organizations to use their existing software to uncover much deeper connections within much larger graphs than possible today. These unique capabilities allow organizations to reimagine the potential of graph analytics, AI and ML and address intractable challenges in fraud detection, cybersecurity, blockchain, risk assessment, healthcare and many other fields. Lucata delivers extreme, high performance for a broad range of common Big Data computing use cases which cannot be cost-effectively addressed with conventional computer architectures.

Learn More
More information about the next generation Lucata architecture is available on the Lucatawebsite including:

  • Lucata Pathfinder description (https://lucata.com/solutions/pathfinder/)
  • Lucata Pathfinder datasheet (https://lucata.com/wp-content/uploads/2021/07/Lucata-Pathfinder-S-Datasheet-070921.pdf)
  • Lucata Tech Brief (https://lucata.com/resources/tech-briefs/) on next generation computing
  • Lucata performance benchmarks (https://lucata.com/resources/benchmarks/)
  • Lucata use cases (https://lucata.com/use-cases/)

About Lucata
The Lucata next generation Context Flow Architecture leverages Intel technology to enable organizations to accelerate and scale graph analytics orders of magnitude beyond the capabilities of conventional computing approaches. Lucata leverages patented Migrating Thread technology to massively scale unified memory and conduct high-performance graph analytics, including exhaustive breadth-first search.

All product and company names herein may be trademarks of their registered owners.

CONTACTS:
Brigit Valencia
brigit@compel-pr.com
(360) 609-3775


© 2022 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.